Why peptides are lyophilised

Why remove water

Lyophilisation, commonly called freeze-drying, is widely used to convert peptide solutions into dry solids that are easier to store and transport. The process is not simply “drying” by evaporation. It is designed to remove water at low temperature by first freezing the formulation and then lowering pressure so that ice sublimes directly from solid to vapour. A final secondary-drying stage removes more tightly bound water by desorption. The objective is a stable solid with controlled residual moisture rather than a heated residue.

The three stages of freeze-drying

Water removal is important because many degradation pathways accelerate in solution. Peptide bonds can hydrolyse, side chains can undergo deamidation, oxidation reactions can proceed more readily, and mobile molecules are more able to interact in ways that promote aggregation or other changes. Lowering molecular mobility in a dry matrix generally slows those processes. Lyophilisation therefore often extends the useful analytical storage window compared with an aqueous solution, although actual stability remains sequence- and formulation-specific.

Formulation and cake structure

The freeze-drying cycle has three major phases. During freezing, water forms ice while solutes become concentrated in the unfrozen fraction. Primary drying applies reduced pressure and controlled heat below the critical temperature of the frozen matrix, allowing ice to sublime while preserving structure. Secondary drying raises temperature carefully to remove residual adsorbed water. The cycle must balance efficiency against physical and chemical stress. If the product temperature exceeds its collapse temperature during primary drying, the cake can lose structure; if residual moisture remains too high, long-term stability may be compromised.

Lyophilised does not mean inert

A lyophilised vial rarely contains only a mathematically pure peptide. Formulations may include buffering agents, bulking agents or stabilisers used to produce a robust cake or maintain pH. Counter-ions from purification can remain associated with the peptide, and some residual moisture is expected. Appearance can therefore vary from a dense cake to a light powder or film without that appearance alone establishing identity or purity. For the same reason, the visible size of the cake is not a reliable estimate of peptide quantity.

Analytical implications

Lyophilisation does not make a peptide indestructible. Dry materials can still degrade through oxidation, light exposure, residual moisture and elevated temperature. Some sequences are particularly sensitive because of methionine, cysteine, tryptophan, asparagine or other reactive residues. Packaging integrity is therefore important. A sealed vial with an effective closure protects against moisture ingress, while cold and dark storage further reduces reaction rates. Opening a cold vial before it equilibrates can draw condensation onto the material, partially defeating the purpose of dry storage.

What lyophilisation actually establishes

Analytically, freeze-drying also changes what should be measured. HPLC purity may describe chromatographic homogeneity, while water content, counter-ion content and residual solvent require separate tests. Nominal fill mass may include formulation components rather than representing peptide alone. A technically complete specification therefore distinguishes peptide identity, chromatographic purity, content or assay where measured, and physical-form attributes.

The core reason peptides are lyophilised is thus controlled stability: remove most water, reduce molecular mobility and create a form that can be stored and handled reproducibly. It is a formulation and preservation strategy, not evidence of purity in itself. The quality of a lyophilised material still depends on the sequence, formulation, cycle design, packaging, storage history and batch-specific analytical results.